An immunotoxin is made safer by the introduction of a point mutation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Smallshaw, J.E. et al. Nat. Biotechnol. 21 387–391 (2003).
Amlot, P.L. et al. Blood 82, 2624–2633 (1993).
Sausville, E.A. et al. Blood 85, 3457–3465 (1995).
Baluna R., Rizo J., Gordon B.E., Ghetie V. & Vitetta E.S. Proc. Natl. Acad.of Sci. USA 96, 3957–3962 (1999).
Baluna R., Coleman E., Jones C., Ghetie V. & Vitetta E.S. Exp. Cell. Res. 258, 417–424 (2002).
Fulton R.J., Tucker T.F., Vitetta E.S. & Uhr J.W. Cancer Res. 48, 2618–2625 (1988).
Thorpe P.E. et al. Cancer Res. 48, 6396–6403 (1988).
Olsen E. et al. J. Clin. Oncol. 19, 376–388 (2001).
Kreitman R.J. et al. New. Engl. J. Med. 345, 241–247 (2001).
Kreitman R.J. et al. J. Clin. Oncol. 18, 1614–1636 (2000).
Frankel A.E., Powell B.L., Hall P.D., Case L.D. & Kreitman R.J. Clin. Cancer Res. 8, 1004–1013 (2002).
Kuan C., Pai L.H. & Pastan I. Clin. Cancer Res. 1, 1589–1594 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kreitman, R. Taming ricin toxin. Nat Biotechnol 21, 372–374 (2003). https://doi.org/10.1038/nbt0403-372
Issue Date:
DOI: https://doi.org/10.1038/nbt0403-372